Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-24
DOI
10.3389/fonc.2020.00992
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
- (2020) Maximilian M. L. Knott et al. CANCER AND METASTASIS REVIEWS
- Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
- (2020) Joanna Achinger-Kawecka et al. Nature Communications
- Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells
- (2020) Asmita Sharda et al. Clinical Epigenetics
- Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response
- (2020) Qingyang Xiao et al. Journal of Clinical Medicine
- Metabolic Plasticity in Chemotherapy Resistance
- (2020) Maria Andrea Desbats et al. Frontiers in Oncology
- Loci specific epigenetic drug sensitivity
- (2020) Thanutra Zhang et al. NUCLEIC ACIDS RESEARCH
- Genetic and epigenetic aberrations of ABCB1 synergistically boost the acquisition of taxane resistance in esophageal squamous cancer cells
- (2020) Anton Sumarpo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- Developing Targeted Therapies That Exploit Aberrant Histone Ubiquitination in Cancer
- (2019) Lucile Jeusset et al. Cells
- Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition
- (2019) Arnaud Augert et al. Science Signaling
- LSD1 Inhibition Attenuates Tumor Growth by Disrupting PLK1 Mitotic Pathway
- (2019) Priya S. Dalvi et al. MOLECULAR CANCER RESEARCH
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail
- (2019) Linlin Lu et al. CELL DEATH AND DIFFERENTIATION
- DNA hypermethylation within TERT promoter upregulates TERT expression in cancer
- (2019) Donghyun D. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance
- (2019) Barbara Marengo et al. Oxidative Medicine and Cellular Longevity
- Epithelial-mesenchymal transition of cancer cells using bioengineered hybrid scaffold composed of hydrogel/3D-fibrous framework
- (2019) Mintu Pal et al. Scientific Reports
- Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide
- (2019) Chanju Lee et al. Journal for ImmunoTherapy of Cancer
- Modulation of CD81 By Epigenetic Drug Combination Sensitizes Acute Lymphoblastic Leukemia Via Decreased BTK Signaling
- (2019) Anthony Quagliano et al. BLOOD
- Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
- (2019) Fujun Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance
- (2019) Catarina Macedo-Silva et al. Genes
- Epigenetic Regulation of miRNA Expression in Malignant Mesothelioma: miRNAs as Biomarkers of Early Diagnosis and Therapy
- (2019) Marco Tomasetti et al. Frontiers in Oncology
- A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
- (2019) Amit M. Oza et al. CLINICAL CANCER RESEARCH
- Combining epigenetic and immune therapy to overcome cancer resistance
- (2019) Stephanie Gomez et al. SEMINARS IN CANCER BIOLOGY
- Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: a role in cancer therapy?
- (2019) Marvin Sylvestre et al. Epigenomics
- Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer
- (2019) Rosaria Benedetti et al. Cancers
- Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
- (2018) Lingzhi Wang et al. CANCER LETTERS
- Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (SLFN11)Expression with Class I Histone Deacetylase Inhibitors
- (2018) Sai-Wen Tang et al. CLINICAL CANCER RESEARCH
- An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations
- (2018) Nicholas Pulliam et al. CLINICAL CANCER RESEARCH
- Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cells
- (2018) Logeswari Ponnusamy et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A
- (2018) Qingqing Xu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Induction of Thioredoxin-Interacting Protein by Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma
- (2018) Paul L. Feingold et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells
- (2018) Luc Gailhouste et al. Cell Death & Disease
- LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
- (2018) T. Boulding et al. Scientific Reports
- DNA Damage, Repair, and Cancer Metabolism
- (2018) Marc-Olivier Turgeon et al. Frontiers in Oncology
- Abstract 2940: Chemosensitization of cholangiocarcinoma by guadecitabine
- (2018) Oliver Surriga et al. CANCER RESEARCH
- DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling
- (2018) Kazuya Ishiguro et al. HAEMATOLOGICA
- KDM4B-regulated unfolded protein response as a therapeutic vulnerability in PTEN-deficient breast cancer
- (2018) Wenyu Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
- (2018) Janet K. Parrish et al. Oncotarget
- Biophysics of Tumor Microenvironment and Cancer Metastasis - A Mini Review
- (2018) Bashar Emon et al. Computational and Structural Biotechnology Journal
- The role of the unfolded protein response in cancer progression: From oncogenesis to chemoresistance
- (2018) Emma Madden et al. BIOLOGY OF THE CELL
- Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations
- (2018) Xiangbing Meng et al. DISEASE MARKERS
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
- (2018) Daniel A. Pollyea et al. NATURE MEDICINE
- Clinical epigenetics: seizing opportunities for translation
- (2018) María Berdasco et al. NATURE REVIEWS GENETICS
- Functions and mechanisms of non-histone protein acetylation
- (2018) Takeo Narita et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death
- (2018) Yuxuan Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
- (2018) Vera Miranda-Gonçalves et al. Frontiers in Genetics
- A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers
- (2017) Philipp Y Maximov et al. ENDOCRINE-RELATED CANCER
- Panobinostat sensitizes KRAS-mutant non-small-cell lung cancer to gefitinib by targeting TAZ
- (2017) Wen-Ying Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Procaine is a specific DNA methylation inhibitor with anti-tumor effect for human gastric cancer
- (2017) Yong-Chao Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Epigenetic drug combination induces remission in mouse xenograft models of pediatric acute myeloid leukemia
- (2017) Anilkumar Gopalakrishnapillai et al. LEUKEMIA RESEARCH
- Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia
- (2017) Anthony Quagliano et al. LEUKEMIA RESEARCH
- Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat
- (2017) Kenneth Kin-Wah To et al. LUNG CANCER
- Radiosensitization In Vivo by Histone Deacetylase Inhibition with No Increase in Early Normal Tissue Radiation Toxicity
- (2017) Blaz Groselj et al. MOLECULAR CANCER THERAPEUTICS
- Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner
- (2017) Konstantinos Dimopoulos et al. Molecular Oncology
- Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells
- (2017) Cornelia Siebenkäs et al. PLoS One
- Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
- (2017) Meredith L. Stone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia
- (2017) Sonali P. Barwe et al. SEMINARS IN ONCOLOGY
- Targeting CD146 in combination with vorinostat for the treatment of ovarian cancer cells
- (2017) Xiaoli Ma et al. Oncology Letters
- Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases
- (2017) Monica Civallero et al. Oncotarget
- Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
- (2017) Tri Nguyen et al. Oncotarget
- Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy
- (2017) Christine S. Young et al. Oncotarget
- Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies
- (2017) Angel Chao et al. Oncotarget
- Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis
- (2017) Simin Kiany et al. OncoImmunology
- Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy
- (2017) Jingjing Li et al. Scientific Reports
- Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential
- (2016) Anna Kazanets et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR
- (2016) L. Zhou et al. BLOOD
- Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response
- (2016) Bryan J. Schneider et al. CLINICAL CANCER RESEARCH
- Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib
- (2016) Andrew J. Wilson et al. GYNECOLOGIC ONCOLOGY
- Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor – Synergistic action of quercetin and curcumin
- (2016) Vikas Sharma et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Overcoming resistance to HER2 inhibitors through state-specific kinase binding
- (2016) Chris J Novotny et al. Nature Chemical Biology
- Targeting the cancer epigenome for therapy
- (2016) Peter A. Jones et al. NATURE REVIEWS GENETICS
- Trichostatin A increases radiosensitization of tongue squamous cell carcinoma via miR-375
- (2016) Lingfei Jia et al. ONCOLOGY REPORTS
- Histone Modifications and Cancer
- (2016) James E. Audia et al. Cold Spring Harbor Perspectives in Biology
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- Lysine-Specific Demethylase 1 (LSD1) Inhibitor S2101 Induces Autophagy via the AKT/mTOR Pathway in SKOV3 Ovarian Cancer Cells
- (2016) Shujun Feng et al. MEDICAL SCIENCE MONITOR
- Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia
- (2015) Hamid Ali Nagi Al-Jamal et al. BMC CANCER
- The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells
- (2015) Gabriele Greve et al. BMC CANCER
- Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy
- (2015) Raafat A El-Awady et al. CANCER BIOLOGY & THERAPY
- Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo
- (2015) Wenxiu Qi et al. CANCER BIOLOGY & THERAPY
- ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
- (2015) S. Meidhof et al. EMBO Molecular Medicine
- The epigenetic agents suberoylanilide hydroxamic acid and 5-AZA-2′ deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo
- (2015) JOHANA M. SUSANTO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin
- (2015) Yuting Kuang et al. Molecular Oncology
- Decitabine Nanoconjugate Sensitizes Human Glioblastoma Cells to Temozolomide
- (2015) Yi Cui et al. MOLECULAR PHARMACEUTICS
- Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer
- (2015) HAIQIU LIAO et al. ONCOLOGY REPORTS
- The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression
- (2015) Xiaolu Zhang et al. Oncotarget
- Upregulation of microRNA-492 induced by epigenetic drug treatment inhibits the malignant phenotype of clear cell renal cell carcinoma in vitro
- (2015) AIBING WU et al. Molecular Medicine Reports
- A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression
- (2014) Jangsoon Lee et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
- (2014) Xiaojing Yang et al. CANCER CELL
- Epigenetic Interventions Increase the Radiation Sensitivity of Cancer Cells
- (2014) Juan Ren et al. CURRENT PHARMACEUTICAL DESIGN
- 5-Azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation
- (2014) MATHIAS FÜLLER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Histone Deacetylase Inhibitor Sensitizes Apoptosis-Resistant Melanomas to Cytotoxic Human T Lymphocytes through Regulation of TRAIL/DR5 Pathway
- (2014) A. R. Jazirehi et al. JOURNAL OF IMMUNOLOGY
- Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor
- (2014) Shohreh Alizadeh Shargh et al. MEDICAL ONCOLOGY
- Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer
- (2014) Donatella Del Bufalo et al. Molecular Cancer
- BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen
- (2014) V. Sahai et al. MOLECULAR CANCER THERAPEUTICS
- Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia
- (2014) Sarah M. Leonard et al. PLoS One
- Combination of Gefitinib and DNA Methylation Inhibitor Decitabine Exerts Synergistic Anti-Cancer Activity in Colon Cancer Cells
- (2014) Yun-feng Lou et al. PLoS One
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Zebularine induces chemosensitization to methotrexate and efficiently decreases AhR gene methylation in childhood acute lymphoblastic leukemia cells
- (2013) Augusto F. Andrade et al. ANTI-CANCER DRUGS
- Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin
- (2013) Maria Antonietta Sabatino et al. Epigenetics
- The Induction of microRNA-16 in Colon Cancer Cells by Protein Arginine Deiminase Inhibition Causes a p53-Dependent Cell Cycle Arrest
- (2013) Xiangli Cui et al. PLoS One
- Panobinostat Synergistically Enhances the Cytotoxic Effects of Cisplatin, Doxorubicin or Etoposide on High-Risk Neuroblastoma Cells
- (2013) Guan Wang et al. PLoS One
- Reactivation of Estrogen Receptor α by Vorinostat Sensitizes Mesenchymal-Like Triple-Negative Breast Cancer to Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor
- (2013) Karri Stark et al. PLoS One
- Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma
- (2013) T. Clozel et al. Cancer Discovery
- Combined Treatment with Low Concentrations of Decitabine and SAHA Causes Cell Death in Leukemic Cell Lines but Not in Normal Peripheral Blood Lymphocytes
- (2013) Barbora Brodská et al. Biomed Research International
- Epigenomics of cancer – emerging new concepts
- (2012) Melanie R. Hassler et al. BIOCHIMIE
- Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
- (2012) John L McElwee et al. BMC CANCER
- Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
- (2012) Jueng Soo You et al. CANCER CELL
- Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways
- (2012) Xue-Jie Jiang et al. CANCER LETTERS
- Histone phosphorylation
- (2012) Dorine Rossetto et al. Epigenetics
- Epigenetic Regulation of Cell Adhesion and Communication by Enhancer of Zeste Homolog 2 in Human Endothelial Cells
- (2012) Henryk Dreger et al. HYPERTENSION
- Decitabine and Vorinostat Cooperate To Sensitize Colon Carcinoma Cells to Fas Ligand-Induced Apoptosis In Vitro and Tumor Suppression In Vivo
- (2012) D. Yang et al. JOURNAL OF IMMUNOLOGY
- Histone ADP-Ribosylation Facilitates Gene Transcription by Directly Remodeling Nucleosomes
- (2012) R. Martinez-Zamudio et al. MOLECULAR AND CELLULAR BIOLOGY
- EWS/FLI1 Regulates EYA3 in Ewing Sarcoma via Modulation of miRNA-708, Resulting in Increased Cell Survival and Chemoresistance
- (2012) T. P. Robin et al. MOLECULAR CANCER RESEARCH
- Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models
- (2012) Li Shen et al. PLoS One
- Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer
- (2011) K Takezawa et al. BRITISH JOURNAL OF CANCER
- Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: Efficacy and underlying mechanisms
- (2011) Sabine Mueller et al. CANCER LETTERS
- Functional Activation of the Estrogen Receptor- and Aromatase by the HDAC Inhibitor Entinostat Sensitizes ER-Negative Tumors to Letrozole
- (2011) G. J. Sabnis et al. CANCER RESEARCH
- Epigenetic regulation of cellular adhesion in cancer
- (2011) J. Katto et al. CARCINOGENESIS
- Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL
- (2011) Vitaliy O. Kaminskyy et al. CARCINOGENESIS
- Epigenetic modifications in cancer
- (2011) R Kanwal et al. CLINICAL GENETICS
- HDAC inhibitors with different gene regulation activities depend on the mitochondrial pathway for the sensitization of leukemic T cells to TRAIL-induced apoptosis
- (2010) J.C. Morales et al. CANCER LETTERS
- Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition
- (2010) T Lin et al. ONCOGENE
- Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer
- (2010) Constanze Zeller et al. Therapeutic Advances in Medical Oncology
- Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
- (2009) D. D. Vo et al. CANCER RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
- (2009) Claudio Festuccia et al. ENDOCRINE-RELATED CANCER
- An operational definition of epigenetics
- (2009) S. L. Berger et al. GENES & DEVELOPMENT
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Epigenetics: Definition, Mechanisms and Clinical Perspective
- (2009) Cathérine Dupont et al. SEMINARS IN REPRODUCTIVE MEDICINE
- Cancer stem cell epigenetics and chemoresistance
- (2009) Francesco Crea et al. Epigenomics
- Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist
- (2008) A. J. Frew et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now